Huons Preprep Powder
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
Huons Co., Ltd.
MFDS item code 201402879 · Notified 2014.06.27 · Insurance code 670606990
Bowel cleansing as preparation before colonoscopy
This medication is used to thoroughly cleanse the bowel before a colonoscopy or X-ray examination. It is important to empty the bowels cleanly for accurate diagnosis, and this product serves that purpose. It helps reduce discomfort during examinations and increases accuracy. Therefore, this drug is used for bowel cleansing purposes before the examination.
For adults aged 18 years and older, take the doses as described below, either divided or as a single evening dose. 1) Split-dose regimen: On the evening before colonoscopy, take 1L of the prepared solution (prepare 500mL of solution × 2 times) over 1 hour (one 250mL cup every 15 minutes), then drink an additional 500mL of water. The following morning, take 1L of the prepared solution (prepare 500mL of solution × 2 times) over 1 hour, then drink an additional 500mL of water. This process must be completed at least 1 hour before the start of colonoscopy. 2) Non-split (evening) regimen: At around 6 p.m. on the evening before colonoscopy, take 1L of the prepared solution (prepare 500mL of solution × 2 times) over 1 hour (one 250mL cup every 15 minutes). After 1.5 hours, take 1L of the prepared solution (prepare 500mL of solution × 2 times) over 1 hour, then drink an additional 1L of water.
This medication may rarely cause generalized tonic-clonic seizures in patients with no history of seizures, so caution should be exercised in cases of electrolyte imbalance. Patients taking medications that can cause electrolyte imbalances, or those suspected of having hyponatremia, should be careful when using this drug. It is advisable to conduct laboratory tests for sodium, potassium, calcium, creatinine, blood urea nitrogen (BUN), etc., before and after the colonoscopy. This medication should not be used in patients with bowel obstruction, gastrointestinal obstruction, perforation, toxic colitis, or toxic megacolon, and should be used cautiously in patients with severe ulcerative colitis. Patients who have hypersensitivity to this drug or its components, those suspected of having gastrointestinal obstruction or perforation, those with dehydration or severe heart failure, those with active cancer, those with gastroparesis, etc., should not use this medication. This medication is also not used in patients with glucose-6-phosphate dehydrogenase deficiency, coma patients, or children under 18 years. Patients with bowel stricture or severe constipation, elderly patients, debilitated patients, those with vomiting reflex disorders, and those with severe renal impairment should use this drug with extra caution. Adverse reactions such as hunger, hypophosphatemia, hypokalemia, sleep disorders, dizziness, headache, abdominal pain, nausea, abdominal distension, fatigue, thirst, and tremors have been reported. Also, allergic reactions or gastrointestinal bleeding, cardiac problems, etc., may occur, so if symptoms arise, immediate consultation with healthcare professionals is necessary. Before and after administration, the patient's bowel movement status should be checked, and if there is severe abdominal distension or pain, the administration speed should be adjusted or stopped as necessary. If symptoms of fluid or electrolyte imbalance occur, blood tests should be performed to assess the condition, and appropriate treatment should be received. This medication can cause diarrhea, so adequate fluid intake is necessary, and the use of irritant laxatives should be avoided. It is recommended to finish meals at least 1 hour before administration and to avoid solid food intake, and while the effects on driving or operating machinery are unknown, caution is advisable. This drug may interfere with the absorption of other oral medications, so it is preferable not to take other medications within 1 hour before and after administration. Pregnant or breastfeeding women should only use this medication when the diagnostic benefits outweigh the risks due to the lack of established safety.
Hunger, hypophosphatemia, hypokalemia, sleep disorders, dizziness, headache, upper abdominal pain, abdominal pain, nausea, abdominal distension, anal discomfort, vomiting, indigestion, dysphagia, fatigue, thirst, tremors, discomfort, decrease in serum bicarbonate, decrease in serum calcium, hypercalcemia, decrease or increase in serum chloride, increase in serum phosphate, liver dysfunction, rash, urticaria, runny nose, dermatitis, edema, anaphylactic-like reaction, upper gastrointestinal bleeding due to gastric mucosal damage, esophageal perforation, cardiac asystole, acute pulmonary edema, tachycardia, palpitations, hypertension, arrhythmia, atrial fibrillation, peripheral edema, syncope, dehydration, anaphylactic reaction, pruritus, lip swelling, tongue swelling, facial swelling, dyspnea, chest tightness, throat tightness, fever, chills, tremors, seizures, renal dysfunction, renal failure
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is advisable to store it at room temperature between 1 and 30 degrees Celsius.
A Preparation: A white or slightly yellow powder with a lemon scent, contained in an aluminum foil pouch. B Preparation: A white to slightly yellow crystalline or crystalline powder without any odor and with a sour taste, contained in an aluminum foil pouch.
4 pouches of A Preparation + 4 pouches of B Preparation / Box
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
Huons Co., Ltd.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
Taejun Pharmaceutical Co., Ltd.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
Hanook Pharma Co., Ltd.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
Albozen Korea Co., Ltd.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
Korea Pavis Pharmaceutical Co., Ltd.
Sodium Chloride 1.3455g · Potassium Chloride 0.5075g +4 more
Prescription medication · Combination
Highple Biomedical Co., Ltd.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
IntroBioPharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.